Related Experiment Video

Updated: Jun 22, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Transmission of respiratory syncytial virus at the paediatric intensive-care unit: a prospective study using

A C van de Pol1, J W A Rossen, T F W Wolfs

  • 1Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, The Netherlands. a.c.vandepol-3@umcutrecht.nl

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|June 16, 2009
PubMed

Insights

Routine infection control measures effectively prevent respiratory syncytial virus (RSV) transmission in pediatric intensive care units (PICUs). A sensitive PCR method found no RSV spread among lower respiratory tract infection (LRTI) patients during the study.

Area of Science:

  • Pediatric Infectious Diseases
  • Intensive Care Medicine
  • Virology

Background:

  • Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infections (LRTI) in children.
  • Preventing nosocomial transmission of RSV in pediatric intensive care units (PICUs) is crucial for patient safety.
  • The effectiveness of current infection control measures against RSV in PICUs requires ongoing evaluation.

Purpose of the Study:

  • To assess the transmission of RSV among patients in a PICU setting.
  • To determine the efficacy of existing infection control protocols in preventing RSV spread.
  • To utilize a highly sensitive diagnostic method for accurate detection of RSV transmission.

Main Methods:

  • Employed a highly sensitive real-time PCR assay to detect RSV.
  • Monitored 24 children with confirmed RSV LRTI for potential transmission (239 exposure days).
  • Tracked 48 RSV-negative patients for acquisition of RSV every 5 days (683 exposure days).

Main Results:

  • No instances of RSV transmission were documented among the studied patient cohort.
  • The sensitive PCR method did not detect any secondary RSV infections originating within the PICU.
  • Despite close proximity and shared environment, no viral spread was observed.

Conclusions:

  • Current infection control measures for LRTI patients in PICUs appear adequate for preventing RSV transmission.
  • The findings support the continued use and adherence to standard infection control practices.
  • Further research may explore specific components of these measures contributing to their success.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Real Time RT-PCR02:57

Real Time RT-PCR

Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...